Covidien
- COV
- NYSE
- Consumer Products
- Latest 65.82
- Currency US$
- Change 0.28
- Percent Change 0.427 %
- Volume 2,165,289
- Tue May 21, 2013 2:59 PM EDT NYSE data delayed 15 minutes.
The Globe and Mail
- Open 65.82
- Previous Close 65.54
- High 66.08
- Low 65.56
- Bidx2 65.81
- Askx3 65.82
- 52-week High 04/11 68.83
- 52-week Low 06/04 50.25
- Beta 1.043
- Market Cap 31,069.67M
- EPS 4.30
- P/E 15.30
- Forward P/E 16.212
- PEG 1.86
- Annual Dividend 1.04
- Yield 1.58
News
- Covidien's Technology Platform to Diagnose Early Lung Cancer Part of New Guidelines of American College of Chest Physicians
- Covidien Receives FDA 510(k) Clearance for Nellcor™ Pulse Oximetry Motion Claims
- Covidien Announces Pricing of $750 Million Senior Notes Offering
- Covidien Announces Senior Notes Offering
- Covidien and Mallinckrodt to Present at Bank of America Merrill Lynch Conference
Financials & Calendars
- Sales $12,167,000,000
- Earnings $1,846,000,000
- Return on Equity 16.93%
- Cash Flow --
- Cash $1,683,000,000
- Current Ratio 2.20
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $22,610,000,000
- Liabilities $11,634,000,000
- Liabilities-to-Equity Ratio 1.06
Price Ratios
- Price to Sales 2.55
- Price to Book 2.83
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | Apr 26 | $1.10 | Jul 25 | $0.90 |
| Surprises | Apr 26 | 1.82% | n/a | n/a |
| Dividends | Apr 2 | $0.26 | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended May 21, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
Covidien PLC, formerly Covidien Ltd, is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its business through four segments: Medical Devices, Imaging Solutions, Pharmaceutical Products and Medical Supplies. The Medical Devices segment includes the development, manufacture and sale of endomechanical, soft tissue repair, energy, oximetry and monitoring, airway and ventilation, vascular, SharpSafety and clinical care products; Imaging Solutions, which includes the development, manufacture and marketing of radiopharmaceuticals and contrast products; Pharmaceutical Products, which includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, which includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products.
Officers
- Jose E. Almeida Chairman;President and C.E.O.
- Charles J. Dockendorff C.F.O. and Exec. V.P.
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Head Office
20 ON HATCH LOWER HATCH STREETDUBLIN, L2
DUBLIN
Phone: (353)-1 438-1700
Ideas & Discussion
Live Discussion of COV on StockTwits